Japan signs a contract to purchase 120 million doses of AstraZeneca vaccine

– The Japanese government officially signed a contract to introduce 120 million doses of a novel coronavirus infection (Corona 19) vaccine jointly developed by British pharmaceutical company AstraZeneca and Oxford University, Sankei Shimbun and NHK reported on the 11th.

According to the media, Japanese Minister of Health, Labor and Welfare Tamura Norihisa announced that it has signed a contract to purchase a large amount of the Corona 19 vaccine with AstraZeneca at a press conference after each session on the afternoon. He said he plans to bring it in from January.

The Ministry of Health, Welfare and Labor explained that AstraZeneca and AstraZeneca agreed in principle to supply a vaccine for Corona 19 in August, followed by consultations and signed the contract the day before.

30 million doses of AstraZeneca vaccine are expected to be supplied by the end of March next year. Since the vaccine is assumed to be administered twice per person, the amount introduced by AstraZeneca is 60 million people. The media is that the corona vaccine, which AstraZeneca and Oxford University studied together, showed an overall average of about 70% effectiveness in clinical trials The AstraZeneca vaccine was temporarily suspended in September after a suspected serious side effect occurred in the clinical trial, but the trial was resumed when the UK regulatory authorities confirmed it was safe to proceed with the clinical trial. .

In addition to AstraZeneca, the Ministry of Health, Labor and Welfare agreed in principle with Modena of the US to supply 25 million people by the end of September next year, and with Pfizer in principle to introduce vaccines for 60 million people by June 2021.

The number of Corona 19 patients in Japan reached 17,5236, with 2113 new cases by 6:30 pm on the 11th. Of the confirmed cases, an additional 223 people died, resulting in a total of 2549 deaths.

[서울=뉴시스]